Magnetic Resonance Q Mapping Reveals a Decrease in Microvessel Density in the arcAβ Mouse Model of Cerebral Amyloidosis
暂无分享,去创建一个
Markus Rudin | Jan Klohs | Martina Füchtemeier | Giovanna D. Ielacqua | Felix Schlegel | Felix Schlegel | M. Rudin | M. Füchtemeier | J. Klohs | Jael Xandry | Jael Xandry | G. D. Ielacqua | F. Schlegel | Martina Füchtemeier
[1] D. Ingram,et al. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease , 2005, Brain Research Bulletin.
[2] M. Staufenbiel,et al. Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy , 2011, The Journal of Neuroscience.
[3] C. Rampon,et al. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease , 2011, Neurobiology of Aging.
[4] Mathias Hoehn,et al. In-Vivo Visualization of Tumor Microvessel Density and Response to Anti-Angiogenic Treatment by High Resolution MRI in Mice , 2011, PloS one.
[5] C. Cotman,et al. Pathogenic amyloid beta-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[6] B. Hyman,et al. Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .
[7] D Le Bihan,et al. Contribution of Sinerem® used as blood‐pool contrast agent: Detection of cerebral blood volume changes during apnea in the rabbit , 1996, Magnetic resonance in medicine.
[8] M. Verbeek,et al. Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein , 1997 .
[9] P. Dederen,et al. Microvascular cerebral blood volume changes in aging APPswe/PS1dE9 AD mouse model: a voxel-wise approach , 2012, Brain Structure and Function.
[10] J. Reichenbach,et al. Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in the Arcabeta Mouse Model of Cerebral Amyloidosis , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] P. Hof,et al. Brain Microvascular Changes in Alzheimer's Disease and Other Dementias a , 1997, Annals of the New York Academy of Sciences.
[12] Thomas Krucker,et al. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.
[13] Dietmar Rudolf Thal,et al. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances , 2009, Neurobiology of Aging.
[14] Hiroshi Matsuda,et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.
[15] Toshio Moritani,et al. Toward fully automated processing of dynamic susceptibility contrast perfusion MRI for acute ischemic cerebral stroke , 2010, Comput. Methods Programs Biomed..
[16] M. Dhenain,et al. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease , 2012, Neurobiology of Aging.
[17] Arne Møller,et al. The capillary dysfunction hypothesis of Alzheimer's disease , 2013, Neurobiology of Aging.
[18] Haiying Tang,et al. Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice , 2004, Neuroscience Letters.
[19] N. Schuff,et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.
[20] Roger M. Nitsch,et al. Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice , 2007, Neurobiology of Aging.
[21] François Hébert,et al. Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.
[22] A P Pathak,et al. Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.
[23] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[24] C. Cotman,et al. Pathogenic amyloid β-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells , 1999 .
[25] Thomas Krucker,et al. Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease , 2003, The Journal of Neuroscience.
[26] R. Nitsch,et al. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation , 2012, Translational Psychiatry.
[27] M. Scheunemann,et al. Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice , 2006, International Journal of Developmental Neuroscience.
[28] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[29] R. Nitsch,et al. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. , 2007, Neurobiology of aging.
[30] V. Kiselev,et al. The Potential of Microvessel Density in Prediction of Infarct Growth: A Two-Month Experimental Study in Vessel Size Imaging , 2012, Cerebrovascular Diseases.
[31] Markus Rudin,et al. Contrast-Enhanced Magnetic Resonance Microangiography Reveals Remodeling of the Cerebral Microvasculature in Transgenic ArcAβ Mice , 2012, The Journal of Neuroscience.
[32] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[33] Joanna M. Wardlaw,et al. Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis , 2009, Neurobiology of Aging.
[34] F. Metzger,et al. Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: Comprehensive phenotyping of vascular and tissular parameters by MRI , 2009, Magnetic resonance in medicine.
[35] Peter Brunecker,et al. Vessel Size Imaging Reveals Pathological Changes of Microvessel Density and Size in Acute Ischemia , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Oscar L Lopez,et al. The growing burden of Alzheimer's disease. , 2011, The American journal of managed care.
[37] Leif Østergaard,et al. Principles of cerebral perfusion imaging by bolus tracking , 2005, Journal of magnetic resonance imaging : JMRI.
[38] Aileen Schroeter,et al. Early Alterations in Functional Connectivity and White Matter Structure in a Transgenic Mouse Model of Cerebral Amyloidosis , 2014, The Journal of Neuroscience.
[39] Marc Dhenain,et al. Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer’s disease , 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.
[40] L. Fratiglioni,et al. Dementia prevention: current epidemiological evidence and future perspective , 2012, Alzheimer's Research & Therapy.
[41] E. Meyer,et al. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice , 2011, Acta Neuropathologica.
[42] J. C. de la Torre. Impaired brain microcirculation may trigger Alzheimer's disease. , 1994, Neuroscience and biobehavioral reviews.
[43] Wiesje M van der Flier,et al. Brain microbleeds and Alzheimer's disease: innocent observation or key player? , 2011, Brain : a journal of neurology.
[44] P. Grammas,et al. Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.
[45] Mark A. van Buchem,et al. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6T , 2012, NeuroImage.
[46] B. Hyman,et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. , 1995, Annals of neurology.
[47] M. Mullan,et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.
[48] M. A. Bell,et al. The Correlation of Vascular Capacity with the Parenchymal Lesions of Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[49] R. Chandra,et al. MR imaging of microvasculature , 2000, Magnetic resonance in medicine.
[50] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[51] D. Bates,et al. Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.
[52] B. D. Ward,et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. , 2004, AJNR. American journal of neuroradiology.
[53] G. Hellermann,et al. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. , 2001, Neurological research.
[54] M. Mullan,et al. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.
[55] C. Cordonnier. Brain microbleeds , 2010, Practical Neurology.
[56] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[57] L H Cheong,et al. An automatic approach for estimating bolus arrival time in dynamic contrast MRI using piecewise continuous regression models. , 2003, Physics in medicine and biology.
[58] M. Verbeek,et al. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. , 1997, Journal of neurochemistry.
[59] M. Rudin,et al. Imaging of cerebrovascular pathology in animal models of Alzheimer's disease , 2014, Front. Aging Neurosci..
[60] Samuel Valable,et al. In vivo imaging of vessel diameter, size, and density: A comparative study between MRI and histology , 2013, Magnetic resonance in medicine.
[61] L. Østergaard,et al. Comparison of gradient‐ and spin‐echo imaging: CBF, CBV, and MTT measurements by bolus tracking , 2000, Journal of magnetic resonance imaging : JMRI.
[62] G. Hellermann,et al. Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production , 2001 .
[63] Haiying Tang,et al. High‐resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q , 2004, NMR in biomedicine.
[64] P. Carvey,et al. Evidence of angiogenic vessels in Alzheimer’s disease , 2009, Journal of Neural Transmission.
[65] Robia G. Pautler,et al. Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.
[66] Joanes Grandjean,et al. Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging , 2013, PloS one.
[67] Kaan E. Biron,et al. Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease , 2011, PloS one.
[68] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[69] V. Fischer,et al. Altered angioarchitecture in selected areas of brains with Alzheimer's disease , 2004, Acta Neuropathologica.
[70] Aline Seuwen,et al. Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[71] H. Vinters. Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.
[72] P. Hof,et al. Stereologic Analysis of Microvascular Morphology in the Elderly: Alzheimer Disease Pathology and Cognitive Status , 2006, Journal of neuropathology and experimental neurology.
[73] M T Madsen,et al. A simplified formulation of the gamma variate function , 1992 .
[74] A. Scheibel,et al. DENERVATION MICROANGIOPATHY IN SENILE DEMENTIA, ALZHEIMER TYPE , 1987, Alzheimer disease and associated disorders.
[75] J. D. L. Torre. Impaired brain microcirculation may trigger Alzheimer's disease , 1994, Neuroscience & Biobehavioral Reviews.
[76] Irene Otte-Höller,et al. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. , 2005, The American journal of pathology.